Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN - Visualizing the Potential Role of HIF-PH Inhibitors in the Treatment of Anemia in Chronic Kidney Disease


Manage episode 276544969 series 103624
By PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Go online to to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this infographic-based activity, an expert in chronic kidney disease (CKD) discusses anemia in CKD and explores the potential role of HIF-PH inhibitors in the treatment of this condition. Upon completion of this activity, participants will be able to: Identify the epidemiology, pathology, and burden of anemia associated with CKD, Discuss limitations of the current model of treatment for anemia associated with CKD, Differentiate the mechanisms of action of current and emerging treatments for anemia associated with CKD, Recognize the benefits and limitations of current and emerging agents to treat anemia in CKD.

284 episodes